Lancet Series 2016: Sickle Cell Disease
2016
This Lancet Series examines the progress made in the field of treating sickle-cell disease, and the remaining complications still being addressed. Drawing attention to emerging causes of morbidity as patients with the disease begin to live longer, the series focuses on asthma, acute chest syndrome, and other complications in patients with sickle-cell disease. In addition, the series reviews relevant progress made in the fields of epidemiology, genetics, and molecular biology. The series also puts out a call for more research, this time looking to Sub-Saharan Africa and India, where the burden on the health care systems is greatest.
Series papers and articles include:
Lancet Series 2016: Sickle Cell Disease
Source:
Sickle-Cell Disease. The Lancet 2016. https://www.thelancet.com/series/haematology-2016.